FDA Approves First New Flu Drug in Nearly 20 Years

On 10/24/18  the FDA approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours. The approval was granted to Shionogi & Co., Ltd.